TransCode Therapeutics

Filed a patent for "radiolabeled nanoparticles and template directed immunomodulation for cancer therapy" on Tue, June 28, 2022

Filed a patent for "nanoparticles and template directed rig-i agonist precursor compositions and uses thereof for cancer therapy" on Thu, February 8, 2024

Filed a patent for "template directed immunomodulation for cancer therapy" on Thu, May 23, 2024